Prof Lars Bullinger, Charite University Berlin, talking about ...
HARMONY Partner NICE presented a poster at GIN Conference.
Prof Anthony Moorman is sharing his views on clinic data in
Video: What is Big Data for Better Outcomes and what
At 19 June 2018 the Innovative Medicines Initiative
To read: The Future of Patient Data Report
IMI is celebrating its 10th anniversary. We are proud to be
Real-world data (RWD) is health-related data derived from
Big Data has been attributed as having “transformative ...
Read the IMI interview with HARMONY Partners Jan
@HARMONY Talks: Partners, Work Package Leaders and Leaders
@HARMONY Talks: Partners, Work Package Leaders and Leaders
HARMONY presented at the Fifth Annual Life Science R&D Data
HARMONY
Healthcare Alliance for Resourceful Medicine Offensive against Neoplasms in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).